METROPOLIS HEALTHC - stock earnings
METROPOLIS.NS Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | 271.6 million INR | 2.9 billion INR |
2023Q3 | 354.5 million INR | 3.1 billion INR |
2023Q2 | 288.0 million INR | 2.8 billion INR |
2023Q1 | 333.6 million INR | 2.8 billion INR |
2022Q4 | 358.0 million INR | 2.9 billion INR |
2022Q3 | 403.3 million INR | 3.0 billion INR |
2022Q2 | 334.0 million INR | 2.8 billion INR |
2022Q1 | 288.0 million INR | 2.8 billion INR |
2021Q4 | 412.2 million INR | 2.9 billion INR |
2021Q3 | 582.7 million INR | 3.0 billion INR |
2021Q2 | 748.9 million INR | 3.3 billion INR |
2021Q1 | 613.5 million INR | 2.9 billion INR |
2020Q4 | 585.7 million INR | 2.7 billion INR |
2020Q3 | 602.8 million INR | 2.9 billion INR |
2020Q2 | 29.0 million INR | 1.4 billion INR |
2020Q1 | 154.9 million INR | 2.1 billion INR |
2019Q4 | 420.7 million INR | 2.2 billion INR |
2019Q3 | 429.8 million INR | 2.2 billion INR |
2019Q2 | 267.8 million INR | 2.0 billion INR |
2019Q1 | 344.9 million INR | 2.0 billion INR |
2018Q4 | 312.0 million INR | 1.9 billion INR |
2018Q3 | 304.8 million INR | 1.9 billion INR |
2018Q2 | 239.7 million INR | 1.8 billion INR |
METROPOLIS.NS Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | 1.4 billion INR | 11.5 billion INR |
2022 | 2.1 billion INR | 12.3 billion INR |
2021 | 1.8 billion INR | 10.0 billion INR |
2020 | 1.3 billion INR | 8.6 billion INR |
2019 | 1.3 billion INR | 7.6 billion INR |
2018 | 1.0 billion INR | 6.4 billion INR |
2017 | 1.0 billion INR | 5.4 billion INR |
2016 | 768.0 million INR | 4.8 billion INR |
2015 | 609.8 million INR | 4.6 billion INR |
2014 | 565.6 million INR | 3.9 billion INR |
METROPOLIS.NS
Price: ₹1,838.20
Dividend Yield: 0.00%
Forward Dividend Yield: 0.22%
Payout Ratio: 16.72%
Dividend Per Share: 4.00 INR
Earnings Per Share: 24.35 INR
P/E Ratio: 68.53
Exchange: NSI
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 92.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 4